Wave Life Sciences (WVE) Operating Income Growth (1y) (2015 - 2026)
Wave Life Sciences (WVE) Operating Income Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.68 Bn | 464.89 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.76 Bn | 115.51 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.40 Bn | 61.65 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 1,386.07% |
| 10 | Wave Life Sciences | 1.19 Bn | 644.41 Mn | - | 37.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.16% |
| Dec 31, 2025 | -345.86% |
| Sep 30, 2025 | 11.83% |
| Jun 30, 2025 | -50.75% |
| Mar 31, 2025 | -44.54% |
| Dec 31, 2024 | 222.94% |
| Sep 30, 2024 | -1,538.23% |
| Jun 30, 2024 | -49.09% |
| Mar 31, 2024 | -13.78% |
| Dec 31, 2023 | 57.11% |
| Sep 30, 2023 | 111.42% |
| Jun 30, 2023 | 44.33% |
| Mar 31, 2023 | 20.50% |
| Dec 31, 2022 | -20.64% |
| Sep 30, 2022 | -411.36% |
| Jun 30, 2022 | -5.87% |
| Mar 31, 2022 | 12.37% |
| Dec 31, 2021 | -19.12% |
| Sep 30, 2021 | 77.90% |
| Jun 30, 2021 | -3.03% |